Abstract

IN SILICO STUDY OF TERMINALIA CHEBULA AS AN ANTICANCER THERAPY TARGETING DHF REDUCTASE

Ekta Rajkumar Bhagat and D. P. Kawade*

.

Abstract

The study involves the molecular docking of the chemical constituents of Terminalia chebula, with a specific focus on their potential anticancer activity. The information provides a comprehensive overview of the drug discovery and development process, the molecular docking technique, cancer types and causes, and the botanical aspects of Terminalia chebula, the aim, objective, plan of work, and experimental methods for the in- silico study are detailed, along with the findings and conclusions of the molecular docking study. It aims to contribute to the understanding of the potential anti-cancer properties of Terminalia chebula and the design of effective Molecules of cancer treatment.

Keywords: In Silico Study, Terminalia Chebula, Anti-Cancer Therapy, DHF Reductase, Phytoconstituents, Ligands, Receptors, Virtual Screening.